Literature DB >> 6871123

Epidemiological survey of oil distribution centres in Britain.

L Rushton, M R Alderson.   

Abstract

A mortality study of workers employed for at least one year between 1 January 1950 and 31 December 1975 at oil distribution centres from three oil companies in Britain has been carried out. Ninety nine per cent of the population were successfully traced to determine their vital status at 31 December 1975. The mortality observed in the study population was compared with that which would be expected from the mortality rates for all the male population of England and Wales. The overall mortality observed was considerably lower than expected on this basis as was the mortality from stroke, hypertensive disease, bronchitis, and pneumonia. The observed number of deaths from all neoplasms was also much less than expected as were the observed deaths from lung cancer. The observed deaths from ischaemic heart disease approximately equalled those expected overall and in each of the companies, however, and there was no evidence of a "healthy worker effect" for this disease group. The ratio of observed over expected deaths from ischaemic heart disease tended to decrease with increasing age at death, and for most of the job groups overall, the observed and expected deaths were about the same. Raised mortality patterns from ischaemic heart disease were found in several subgroups of the population of one company. Mortality from myelofibrosis and diseases of the lymphatic and haematopoietic tissue was slightly raised overall. Only myelofibrosis showed an overall excess but raised mortality was found in subgroups of the population defined by company, job, and length of service in several of the other neoplasms making up this disease group. The numbers of deaths from these causes were all small, making it difficult to exclude chance effects. Further work would be required to ascertain whether these results are due to an occupational factor and if so to identify the physical or chemical nature of the risk.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871123      PMCID: PMC1069331          DOI: 10.1136/oem.40.3.330

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  15 in total

1.  Cancer of the scrotum in wax pressmen. I. Epidemiology.

Authors:  N V HENDRICKS; C M BERRY; J G LIONE; J J THORPE
Journal:  AMA Arch Ind Health       Date:  1959-05

2.  Skin cancer in the engineering industry from the use of mineral oil.

Authors:  C N D CRUICKSHANK; J R SQUIRE
Journal:  Br J Ind Med       Date:  1950-01

3.  A health survey of petroleum asphalt workers.

Authors:  C H Baylor; N K Weaver
Journal:  Arch Environ Health       Date:  1968-08

4.  Lack of association between cancer incidence and residence near petrochemical industry in the San Francisco Bay area.

Authors:  C D Hearey; H Ury; A Siegelaub; M K Ho; H Salomon; R L Cella
Journal:  J Natl Cancer Inst       Date:  1980-06       Impact factor: 13.506

5.  Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge.

Authors:  N A Soter; S I Wasserman; K F Austen
Journal:  N Engl J Med       Date:  1976-03-25       Impact factor: 91.245

6.  Service station attendants' exposure to benzene and gasoline vapors.

Authors:  H J McDermott; G A Vos
Journal:  Am Ind Hyg Assoc J       Date:  1979-04

7.  Benzene exposures during gasoline loading at bulk marketing terminals.

Authors:  W S Irving; T G Grumbles
Journal:  Am Ind Hyg Assoc J       Date:  1979-06

8.  Mortality among workers employed in petroleum refining and petrochemical plants.

Authors:  T L Thomas; P Decoufle; R Moure-Eraso
Journal:  J Occup Med       Date:  1980-02

9.  An epidemiological survey of eight oil refineries in Britain.

Authors:  L Rushton; M R Alderson
Journal:  Br J Ind Med       Date:  1981-08

10.  Lung cancer and the petroleum industry in Louisiana.

Authors:  M S Gottlieb
Journal:  J Occup Med       Date:  1980-06
View more
  14 in total

1.  Professional drivers in London: a mortality study.

Authors:  R Balarajan; M E McDowall
Journal:  Br J Ind Med       Date:  1988-07

Review 2.  Occupational liver injury. Present state of knowledge and future perspective.

Authors:  M Døssing; P Skinhøj
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

3.  Further follow up of mortality in a United Kingdom oil distribution centre cohort.

Authors:  L Rushton
Journal:  Br J Ind Med       Date:  1993-06

4.  Mortality study of cancer risk among oil refinery workers.

Authors:  P A Bertazzi; A C Pesatori; C Zocchetti; R Latocca
Journal:  Int Arch Occup Environ Health       Date:  1989       Impact factor: 3.015

5.  An industry wide mortality study of chemical workers occupationally exposed to benzene. I. General results.

Authors:  O Wong
Journal:  Br J Ind Med       Date:  1987-06

6.  Cancer incidence and mortality near the Baglan Bay petrochemical works, South Wales.

Authors:  S Sans; P Elliott; I Kleinschmidt; G Shaddick; S Pattenden; P Walls; C Grundy; H Dolk
Journal:  Occup Environ Med       Date:  1995-04       Impact factor: 4.402

7.  Benzene exposure in the petroleum distribution industry associated with leukemia in the United Kingdom: overview of the methodology of a case-control study.

Authors:  L Rushton
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

8.  Leukemia mortality by cell type in petroleum workers with potential exposure to benzene.

Authors:  G K Raabe; O Wong
Journal:  Environ Health Perspect       Date:  1996-12       Impact factor: 9.031

9.  Health effects of gasoline exposure. II. Mortality patterns of distribution workers in the United States.

Authors:  O Wong; F Harris; T J Smith
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

Review 10.  A 39-year follow-up of the U.K. oil refinery and distribution center studies: results for kidney cancer and leukemia.

Authors:  L Rushton
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.